PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-31.82%
Both yoy net incomes decline, with CRK at -66.85%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.87%
D&A growth of 1.87% while CRK is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
176.39%
Well above CRK's 82.87% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
245.16%
Well above CRK's 237.66% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
245.16%
Growth well above CRK's 239.46%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-843.75%
Negative yoy while CRK is 13.50%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
38.84%
Operating cash flow growth at 75-90% of CRK's 48.78%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-5.63%
Negative yoy CapEx while CRK is 9.93%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
103.70%
Acquisition growth of 103.70% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-266.67%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
5.63%
Liquidation growth of 5.63% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-2.44%
Both yoy lines negative, with CRK at -71.20%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-4.25%
We reduce yoy invests while CRK stands at 5.43%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-40.24%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.